Breaking News Instant updates and real-time market news.

EB

Eventbrite

$6.41 /

-0.23 (-3.46%)

06:42
05/18/20
05/18
06:42
05/18/20
06:42

Eventbrite upgraded to Buy from Hold at SunTrust

SunTrust analyst Youssef Squali upgraded Eventbrite to Buy from Hold with a $12 price target.

  • 21

    May

EB Eventbrite
$6.41 /

-0.23 (-3.46%)

05/12/20 Truist
Eventbrite price target raised to $12 from $8 at SunTrust
04/03/20 Truist
Eventbrite price target lowered to $8 from $19 at SunTrust
02/28/20 Truist
Eventbrite price target lowered to $19 from $22 at SunTrust
02/28/20 RBC Capital
Eventbrite downgraded to Sector Perform from Outperform at RBC Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Medallia to collaborate with Visier on HR solution » 08:09
10/26/20
10/26
08:09
10/26/20
08:09
MDLA

Medallia

$32.10 /

+0.645 (+2.05%)

Medallia announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDLA Medallia
$32.10 /

+0.645 (+2.05%)

MDLA Medallia
$32.10 /

+0.645 (+2.05%)

10/05/20 BTIG
Medallia initiated with a Buy at BTIG
09/24/20 Oppenheimer
Medallia recent selloff looks overdone, says Oppenheimer
09/04/20 Truist
Medallia price target raised to $39 from $33 at Truist
09/04/20 Roth Capital
Medallia positioned for further growth, says Roth Capital
MDLA Medallia
$32.10 /

+0.645 (+2.05%)

MDLA Medallia
$32.10 /

+0.645 (+2.05%)

Hot Stocks
Advaxis announces results from combination arm of Phase 1/2 ADXS-503 study » 08:08
10/26/20
10/26
08:08
10/26/20
08:08
ADXS

Advaxis

$0.51 /

+0.0179 (+3.65%)

, MRK

Merck

$79.84 /

+0.63 (+0.80%)

Advaxis (ADXS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADXS Advaxis
$0.51 /

+0.0179 (+3.65%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

ADXS Advaxis
$0.51 /

+0.0179 (+3.65%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
Merck initiated with a Buy at Truist
10/16/20 JPMorgan
Merck price target raised to $105 from $98 at JPMorgan
10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
ADXS Advaxis
$0.51 /

+0.0179 (+3.65%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

Hot Stocks
PTC Therapeutics initiates Phase 2/3 clinical trial to evaluate vatiquinone » 08:08
10/26/20
10/26
08:08
10/26/20
08:08
PTCT

PTC Therapeutics

$51.98 /

-0.02 (-0.04%)

PTC Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

10/07/20 JPMorgan
PTC Therapeutics upgraded to Overweight with $71 target at JPMorgan
10/07/20 JPMorgan
PTC Therapeutics upgraded to Overweight from Neutral at JPMorgan
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/24/20 Raymond James
PTC Therapeutics initiated with an Outperform at Raymond James
PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

Hot Stocks
Exelixis announces 1st patient enrolled trial cohort evaluating XL092 in combo » 08:08
10/26/20
10/26
08:08
10/26/20
08:08
EXEL

Exelixis

$22.31 /

+0.46 (+2.11%)

Exelixis announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
05/14/20 SunTrust
Exelixis price target raised to $40 from $35 at SunTrust
EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

Initiation
Asana initiated with a Sector Weight at KeyBanc » 08:08
10/26/20
10/26
08:08
10/26/20
08:08
ASAN

Asana

$23.51 /

-0.48 (-2.00%)

KeyBanc analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

07:53 Today Oppenheimer
Asana initiated with an Outperform at Oppenheimer
07:51 Today Morgan Stanley
Asana initiated with an Equal Weight at Morgan Stanley
07:33 Today Credit Suisse
Asana initiated with a Neutral at Credit Suisse
06:41 Today RBC Capital
Asana initiated with an Outperform at RBC Capital
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

Hot Stocks
Leidos awarded CPFF contract valued at $306M » 08:07
10/26/20
10/26
08:07
10/26/20
08:07
LDOS

Leidos

$85.76 /

-0.03 (-0.03%)

Leidos has been awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LDOS Leidos
$85.76 /

-0.03 (-0.03%)

LDOS Leidos
$85.76 /

-0.03 (-0.03%)

09/23/20 Barclays
Barclays upgrades Leidos to Overweight, sees above peer growth in 2021
09/23/20 Barclays
Leidos upgraded to Overweight from Equal Weight at Barclays
09/22/20 JPMorgan
Leidos upgraded to Overweight on bottomed estimates at JPMorgan
09/22/20 JPMorgan
Leidos upgraded to Overweight from Neutral at JPMorgan
LDOS Leidos
$85.76 /

-0.03 (-0.03%)

LDOS Leidos
$85.76 /

-0.03 (-0.03%)

LDOS Leidos
$85.76 /

-0.03 (-0.03%)

Hot Stocks
Peabody Energy names Darren Yeates as COO » 08:06
10/26/20
10/26
08:06
10/26/20
08:06
BTU

Peabody Energy

$1.58 /

-0.02 (-1.25%)

Peabody announced Darren…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTU Peabody Energy
$1.58 /

-0.02 (-1.25%)

BTU Peabody Energy
$1.58 /

-0.02 (-1.25%)

08/07/20 Vertical Research
Peabody Energy downgraded to Hold from Buy at Vertical Research
05/07/20 Clarksons Platou
Peabody Energy downgraded to Neutral from Buy at Clarksons Platou
03/20/20 Deutsche Bank
Peabody Energy downgraded to Hold from Buy at Deutsche Bank
02/10/20 Benchmark
Benchmark starts Arch Coal at Buy, sees opportunity after selloff
BTU Peabody Energy
$1.58 /

-0.02 (-1.25%)

BTU Peabody Energy
$1.58 /

-0.02 (-1.25%)

Recommendations
Inspire Brands interest in Dunkin' Brands 'a surprise,' says KeyBanc » 08:06
10/26/20
10/26
08:06
10/26/20
08:06
DNKN

Dunkin' Brands

$88.70 /

-0.5 (-0.56%)

Commenting on The New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

07:12 Today William Blair
Dunkin' Brands unlikely to see other suitors emerge, says William Blair
06:48 Today Baird
Dunkin' Brands price target raised to $106 from $86 at Baird
10/23/20 KeyBanc
Dunkin' Brands price target raised to $97 from $78 at KeyBanc
10/20/20 Cleveland Research
Dunkin' Brands U.S. comps look to have improved, says Cleveland Research
DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

Hot Stocks
Tracon Pharmaceuticals announces FDA orphan drug designation for TRC102 » 08:06
10/26/20
10/26
08:06
10/26/20
08:06
TCON

Tracon Pharmaceuticals

$4.93 /

+0.39 (+8.59%)

TRACON Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$4.93 /

+0.39 (+8.59%)

TCON Tracon Pharmaceuticals
$4.93 /

+0.39 (+8.59%)

09/17/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright
04/24/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
03/10/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $6 from $13 at H.C. Wainwright
02/28/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $13 from $18 at H.C. Wainwright
TCON Tracon Pharmaceuticals
$4.93 /

+0.39 (+8.59%)

Hot Stocks
Bank of Marin announces reactivation of $25M share repurchase program » 08:05
10/26/20
10/26
08:05
10/26/20
08:05
BMRC

Bank of Marin

$32.91 /

+0.53 (+1.64%)

On October 23the Board of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMRC Bank of Marin
$32.91 /

+0.53 (+1.64%)

BMRC Bank of Marin
$32.91 /

+0.53 (+1.64%)

Recommendations
Cleveland-Cliffs price target raised to $13 from $10 at B. Riley Securities » 08:05
10/26/20
10/26
08:05
10/26/20
08:05
CLF

Cleveland-Cliffs

$8.68 /

+0.405 (+4.89%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

09/29/20 Citi
Cleveland-Cliffs acquisition positive for company, industry, says Citi
09/14/20 B. Riley FBR
Cleveland-Cliffs a 'compelling contrarian opportunity,' says B. Riley FBR
07/31/20 GLJ Research
Cleveland-Cliffs downgraded to Sell from Hold at GLJ Research
06/03/20 GLJ Research
Cleveland-Cliffs upgraded to Hold from Sell at GLJ Research
CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

Hot Stocks
Regeneron and Sanofi's Dupixent shows additional Phase 3 positive results » 08:05
10/26/20
10/26
08:05
10/26/20
08:05
REGN

Regeneron

$579.91 /

+4.18 (+0.73%)

, SNY

Sanofi

$49.33 /

+0.39 (+0.80%)

Regeneron (REGN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$579.91 /

+4.18 (+0.73%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

REGN Regeneron
$579.91 /

+4.18 (+0.73%)

10/08/20 Benchmark
Regeneron antibody data 'more convincing' than Eli Lilly's, says Benchmark
10/07/20 Canaccord
Eli Lilly data further validates COVID antibody therapy, says Canaccord
10/05/20 Cantor Fitzgerald
Regeneron upgraded to Overweight from Neutral at Cantor Fitzgerald
10/05/20 Cantor Fitzgerald
Regeneron upgraded to Overweight from Neutral at Cantor Fitzgerald
SNY Sanofi
$49.33 /

+0.39 (+0.80%)

10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
REGN Regeneron
$579.91 /

+4.18 (+0.73%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

  • 27
    May
REGN Regeneron
$579.91 /

+4.18 (+0.73%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

REGN Regeneron
$579.91 /

+4.18 (+0.73%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

REGN Regeneron
$579.91 /

+4.18 (+0.73%)

Hot Stocks
PerkinElmer announces SARS-CoV-2 RT-PCR panel receives CE Mark » 08:05
10/26/20
10/26
08:05
10/26/20
08:05
PKI

PerkinElmer

$124.48 /

-0.7 (-0.56%)

PerkinElmer announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PKI PerkinElmer
$124.48 /

-0.7 (-0.56%)

PKI PerkinElmer
$124.48 /

-0.7 (-0.56%)

09/24/20 Cleveland Research
PerkinElmer's California contract can drive upside, says Cleveland Research
09/11/20 Needham
PerkinElmer upgraded to Buy from Hold at Needham
07/29/20 Wells Fargo
PerkinElmer price target raised to $130 from $105 at Wells Fargo
04/27/20 Cleveland Research
PerkinElmer estimates lowered further on headwinds at Cleveland Research
PKI PerkinElmer
$124.48 /

-0.7 (-0.56%)

PKI PerkinElmer
$124.48 /

-0.7 (-0.56%)

PKI PerkinElmer
$124.48 /

-0.7 (-0.56%)

PKI PerkinElmer
$124.48 /

-0.7 (-0.56%)

Hot Stocks
Silicon Motion extends share repurchase program for 12 months » 08:05
10/26/20
10/26
08:05
10/26/20
08:05
SIMO

Silicon Motion

$39.60 /

-0.38 (-0.95%)

Silicon Motion Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIMO Silicon Motion
$39.60 /

-0.38 (-0.95%)

09/24/20 Wedbush
Silicon Motion upgraded to Outperform at Wedbush
09/24/20 Wedbush
Silicon Motion upgraded to Outperform from Neutral at Wedbush
08/21/20 B. Riley FBR
Silicon Motion valuation 'unusually compelling,' says B. Riley FBR
06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
SIMO Silicon Motion
$39.60 /

-0.38 (-0.95%)

SIMO Silicon Motion
$39.60 /

-0.38 (-0.95%)

Earnings
Koppers Holdings raises FY20 adj. EPS view to $3.65-$3.90 from $3.25-$3.50 » 08:04
10/26/20
10/26
08:04
10/26/20
08:04
KOP

Koppers Holdings

$25.17 /

+0.67 (+2.73%)

FY20 consensus $3.42.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
02/28/20 Barrington
Koppers Holdings price target lowered to $43 from $50 at Barrington
11/11/19 Barrington
Koppers Holdings price target raised to $50 from $35 at Barrington
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

Earnings
Bank of Marin reports Q3 EPS 55c, consensus 52 » 08:04
10/26/20
10/26
08:04
10/26/20
08:04
BMRC

Bank of Marin

$32.91 /

+0.53 (+1.64%)

"We continue to work…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMRC Bank of Marin
$32.91 /

+0.53 (+1.64%)

BMRC Bank of Marin
$32.91 /

+0.53 (+1.64%)

Hot Stocks
Accenture, MIT to co-develop supply chain stress test » 08:04
10/26/20
10/26
08:04
10/26/20
08:04
ACN

Accenture

$229.75 /

+1.54 (+0.67%)

Accenture and the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$229.75 /

+1.54 (+0.67%)

ACN Accenture
$229.75 /

+1.54 (+0.67%)

09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
ACN Accenture
$229.75 /

+1.54 (+0.67%)

ACN Accenture
$229.75 /

+1.54 (+0.67%)

ACN Accenture
$229.75 /

+1.54 (+0.67%)

ACN Accenture
$229.75 /

+1.54 (+0.67%)

Earnings
Lakeland Financial reports Q3 EPS 89c, consensus 71c » 08:03
10/26/20
10/26
08:03
10/26/20
08:03
LKFN

Lakeland Financial

$49.23 /

+1.17 (+2.43%)

Return on average total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LKFN Lakeland Financial
$49.23 /

+1.17 (+2.43%)

LKFN Lakeland Financial
$49.23 /

+1.17 (+2.43%)

Recommendations
Gentex price target raised to $38.75 from $33 at B. Riley Securities » 08:03
10/26/20
10/26
08:03
10/26/20
08:03
GNTX

Gentex

/

+

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNTX Gentex
/

+

GNTX Gentex
/

+

10/22/20 JPMorgan
Gentex price target raised to $30 from $29 at JPMorgan
10/19/20 Baird
Gentex reinstated with an Outperform at Baird
08/07/20 Jefferies
Gentex set up favorably for second half, says Jefferies
07/27/20 KeyBanc
Gentex upgraded to Overweight at KeyBanc on 'significant' earnings power
GNTX Gentex
/

+

Recommendations
SVB Financial price target raised to $350 from $335 at Maxim » 08:03
10/26/20
10/26
08:03
10/26/20
08:03
SIVB

SVB Financial

$296.24 /

+11.73 (+4.12%)

Maxim analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIVB SVB Financial
$296.24 /

+11.73 (+4.12%)

SIVB SVB Financial
$296.24 /

+11.73 (+4.12%)

10/23/20 Oppenheimer
SVB Financial price target raised to $342 from $312 at Oppenheimer
09/29/20 Truist
Truist raises price targets on select regional banks
09/03/20 Raymond James
SVB Financial price target raised to $297 from $260 at Raymond James
07/31/20 Wolfe Research
SVB Financial initiated with an Outperform at Wolfe Research
SIVB SVB Financial
$296.24 /

+11.73 (+4.12%)

Periodicals
Microsoft a 'significant' backer of Biden campaign, Reuters reports » 08:03
10/26/20
10/26
08:03
10/26/20
08:03
MSFT

Microsoft

$216.25 /

+1.43 (+0.67%)

Microsoft has emerged as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$216.25 /

+1.43 (+0.67%)

MSFT Microsoft
$216.25 /

+1.43 (+0.67%)

10/23/20 Morgan Stanley
Citrix downgraded to Equal Weight on slower cloud progress at Morgan Stanley
10/23/20 Barclays
Microsoft price target raised to $249 from $234 at Barclays
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
10/20/20 Stifel
Microsoft price target raised to $245 from $220 at Stifel
MSFT Microsoft
$216.25 /

+1.43 (+0.67%)

MSFT Microsoft
$216.25 /

+1.43 (+0.67%)

MSFT Microsoft
$216.25 /

+1.43 (+0.67%)

MSFT Microsoft
$216.25 /

+1.43 (+0.67%)

MSFT Microsoft
$216.25 /

+1.43 (+0.67%)

Earnings
Koppers Holdings reports preliminary Q3 adjusted EPS $1.64, consensus $1.29 » 08:02
10/26/20
10/26
08:02
10/26/20
08:02
KOP

Koppers Holdings

$25.17 /

+0.67 (+2.73%)

Reports Q3 preliminary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
02/28/20 Barrington
Koppers Holdings price target lowered to $43 from $50 at Barrington
11/11/19 Barrington
Koppers Holdings price target raised to $50 from $35 at Barrington
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

Recommendations
Alpha & Omega price target raised to $22 from $19 at B. Riley Securities » 08:01
10/26/20
10/26
08:01
10/26/20
08:01
AOSL

Alpha & Omega

$16.65 /

+0.26 (+1.59%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AOSL Alpha & Omega
$16.65 /

+0.26 (+1.59%)

10/06/20 B. Riley Securities
Alpha & Omega price target raised to $19 from $17 at B. Riley Securities
08/26/20 B. Riley FBR
B. Riley FBR upgrades Alpha & Omega to Buy, boosts target to $17
08/26/20 B. Riley FBR
Alpha & Omega upgraded to Buy from Neutral at B. Riley FBR
03/19/20 B. Riley FBR
B. Riley FBR downgrades 10 Semiconductor names on escalating risks
AOSL Alpha & Omega
$16.65 /

+0.26 (+1.59%)

AOSL Alpha & Omega
$16.65 /

+0.26 (+1.59%)

Upgrade
Archer Daniels upgraded to Buy ahead of earnings at Monness Crespi » 08:00
10/26/20
10/26
08:00
10/26/20
08:00
ADM

Archer Daniels

/

+

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADM Archer Daniels
/

+

ADM Archer Daniels
/

+

07:39 Today Monness Crespi
Archer Daniels upgraded to Buy from Neutral at Monness Crespi
10/19/20
Fly Intel: Top five analyst upgrades
10/19/20 JPMorgan
Archer Daniels upgraded to Overweight with $60 target at JPMorgan
10/19/20 JPMorgan
Archer Daniels upgraded to Overweight from Neutral at JPMorgan
ADM Archer Daniels
/

+

ADM Archer Daniels
/

+

ADM Archer Daniels
/

+

ADM Archer Daniels
/

+

Recommendations
Skyworks price target raised to $190 from $170 at B. Riley Securities » 08:00
10/26/20
10/26
08:00
10/26/20
08:00
SWKS

Skyworks

$149.79 /

+0.1 (+0.07%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWKS Skyworks
$149.79 /

+0.1 (+0.07%)

SWKS Skyworks
$149.79 /

+0.1 (+0.07%)

10/20/20 Goldman Sachs
Skyworks price target raised to $159 from $140 at Goldman Sachs
10/19/20 Mizuho
Skyworks price target raised to $170 from $145 at Mizuho
10/14/20 KeyBanc
Apple iPhone launch positive for Broadcom, Qualcomm, says KeyBanc
09/29/20 Piper Sandler
Skyworks price target raised to $160 from $150 at Piper Sandler
SWKS Skyworks
$149.79 /

+0.1 (+0.07%)

SWKS Skyworks
$149.79 /

+0.1 (+0.07%)

SWKS Skyworks
$149.79 /

+0.1 (+0.07%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.